JPM Thematics - Genetic Therapies I2 Fonds
75,17
EUR
+0,21
EUR
+0,28
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 3,59% |
| Novartis AG Registered Shares | CH0012005267 | 3,37% |
| Gilead Sciences Inc | US3755581036 | 3,24% |
| PTC Therapeutics Inc | US69366J2006 | 3,21% |
| Astellas Pharma Inc | JP3942400007 | 3,06% |
| Amgen Inc | US0311621009 | 3,05% |
| Ionis Pharmaceuticals Inc | US4622221004 | 2,94% |
| Lonza Group Ltd | CH0013841017 | 2,72% |
| Bristol-Myers Squibb Co | US1101221083 | 2,72% |
| BioMarin Pharmaceutical Inc | US09061G1013 | 2,70% |
| Sonstige | 69,41% |